Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 111.20M P/E - EPS this Y -6.90% Ern Qtrly Grth -
Income -12.61M Forward P/E -4.94 EPS next Y -0.70% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 8.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -17.00%
Recommedations 2.00 Quick Ratio 1.60 Shares Outstanding 15.98M 52W Low Chg 63.00%
Insider Own 12.27% ROA -85.45% Shares Float 11.64M Beta 1.75
Inst Own 13.79% ROE - Shares Shorted/Prior 677.91K/795.90K Price 6.91
Gross Margin - Profit Margin - Avg. Volume 110,890 Target Price 18.00
Oper. Margin - Earnings Date Jun 10 Volume 232,164 Change 1.62%
About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

BriaCell Therapeutics Corp. News
04/10/24 BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
04/09/24 BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
03/07/24 BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
03/06/24 BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
02/27/24 BriaCell Provides Update on Alleged Illegal Trading of Public Securities
02/12/24 Get Rich Quick With These 3 Penny Stocks to Buy Now
02/07/24 BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
02/06/24 Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
01/30/24 BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
01/04/24 BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
12/28/23 BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
12/20/23 BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
12/18/23 BCTX: Down in San Antone
12/06/23 BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS
12/06/23 BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit
12/01/23 Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
11/30/23 BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
11/08/23 BCTX: November 2023 SITC Poster
11/03/23 BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND
11/01/23 BCTX: Year in Review
BCTX Chatroom

User Image ArgusDune1971 Posted - 1 hour ago

$BCTX Don't worry fellow BCTXers, I have it on good authority that "Something big is coming soon" And "The best is yet to come"

User Image Fvalstounge Posted - 3 hours ago

$BCTX So, do you you think "they" (institutional investors) know something you don't? Let's examine that... Certainly, those who manage large sums of money have a skillset that makes them successful. In most cases, you don't hold that position long without success. That said, these people generally don't base their opinions on the finite details of the science. They have numerous other metrics to look at. With the current pace of discovery and innovation, it's hard for the world's best experts to keep up with all the information IN THEIR OWN FIELD. Keeping up with everything is simply impossible. With over 600 biotechs on NASDAQ, hundreds of therapeutic approaches and thousands of clinical trials, there is no investment professional on the planet with the slightest chance of being knowledgeable about them all. Just like the medical professionals, most are specialists, and the rest are ten miles wide and two inches deep. They don't have special insight.

User Image Fvalstounge Posted - 3 hours ago

$BCTX If it weren't for cancer's multiple layers of defenses, the innate & adaptive immune system could attack and destroy the mutated cells. Immunology is based on restoring this ability, but often relies on duplicating what our immune cells already (should) naturally do. While there are many other therapies based on engineered cells, they tend to focus on Dendritic cells, T-Cells, NK cells or STEM cells. Very, very few use cancer cells, and those that tried didn't have the same success. Bria-IMT is able to awaken the immune response, as the breast cancer normally would, WITHOUT the cancer's defenses, giving the immune system a chance to attack. Rather than try to duplicate functions of immune cells, it mimics the CANCER cells, facilitating a natural response. The actual cancer is "invisible" to the immune system and suppresses the response, but our cells teach the immune cells what they should be "seeing". Bria is to the immune system as alien sunglasses are to Rowdy Roddy Piper.

User Image Blameyourselfirst Posted - 7 hours ago

$BCTX I see valuation should be around the same as $IBRX

User Image S0887 Posted - 7 hours ago

$BCTX Something big is coming soon

User Image TickerDD_com Posted - 10 hours ago

From 4/11/2024, looking back across 22 Month-Ends for BCTX, Percentage Change of Average Monthly Price had More Negatives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $BCTX #BCTX #BCTXStock #TickerDD https://www.youtube.com/watch?v=Txl7Y8TPR6Y

User Image a36er Posted - 11 hours ago

$BCTX This was looking interesting until I saw the 13G filings from the parasites over at Sabby.

User Image ArgusDune1971 Posted - 1 day ago

$BCTX Profited shares 0.00% Today's volume 15k If it really puts it's back into it it could find a way be even more pathetic, but its going to be tough.

User Image Blameyourselfirst Posted - 1 day ago

$BCTX A spread is building on ask/bid

User Image Quinnzilla Posted - 2 days ago

$BCTX So is the general consensus that we will get some sort of news between now and the end of July about funding? I think most agreed our cash runway will only carry us to around the end of July. TIA

User Image ArgusDune1971 Posted - 3 days ago

$BCTX People really need to give up on the dream of a mythical "short squeeze" that will rocket us to the moon. Short squeezes are a myth and never happen. A study that was done on the GameStop situation found that very very few shorts actually covered their positions during the meteoric rise of the stock to over 400 a share. It was all just buying. The shorts didn't cover because they knew their bed buddies the SEC would come to their rescue and bail them out. And they did. Short squeezes are a myth. Long squeezes? That's just another day ending in Y. Shorts pile on and force longs who wouldn't normally sell to sell. Thanks SEC, loving getting hit in the sack with a baseball bat repeatedly.

User Image BD12 Posted - 3 days ago

$BCTX A drug that receives Fast Track designation is eligible for some or all of the following: More frequent meetings with FDA to discuss the drug's development plan and ensure collection of appropriate data needed to support drug approval More frequent written communication from FDA about such things as the design of the proposed clinical trials and use of biomarkers Eligibility for Accelerated Approval and Priority Review, if relevant criteria are met With the "stay tuned" comment, I think they're waiting to hear back from the FDA regarding accelerated approval. If they get the accelerated approval, they get the financing done.

User Image Aaab23 Posted - 4 days ago

$BCTX if a big play was to happen 50/10 5x 50/2 25x Simple math . What do I prefer ? 🤔

User Image Blameyourselfirst Posted - 4 days ago

$BCTX Although the Share price gives appearance of a death spiral. The trials results show appearance of blood brain barrier permeability and tumors decrease and disappearance. As said before on this chatboard: The board is loaded up and doesn't act as if they needed any money. You are what you do not what you say you will do. I AM BUYING. I am an investor. A proud one.

User Image Fvalstounge Posted - 4 days ago

$BCTX Shorty's moral compass:

User Image JOSHUAROCKS123 Posted - 4 days ago

$BCTX Citadel Securities blasts Trump Media CEO Nunes over short-selling letter https://www.cnbc.com/2024/04/19/citadel-securities-blasts-trump-media-ceo-over-djt-short-sale-letter.html?__source=androidappshare

User Image fedex11204 Posted - 4 days ago

$BCTX I see people here suggesting low 1’s is a possibility only way I see it getting there is if they do a much-needed offering , which they probably should’ve done a long long time ago

User Image ljar88 Posted - 4 days ago

$BCTX there is nothing to worry about. Do you know why I’ll give you 20 guesses might’ve gotten on the first guess that’s because @JOSHUAROCKS123 says “The best is yet to come”

User Image BabyAlien Posted - 4 days ago

$BCTX up up up

User Image Jay1490 Posted - 4 days ago

$BCTX been here 3 years and new 52 werk lows being hit every time I check in. Should have sold at 12!

User Image ArgusDune1971 Posted - 4 days ago

$BCTX Hammered all day Up 12% after hours. The manipulation crew to the SEC....

User Image FredFlintstock Posted - 4 days ago

$BCTX oh boy, almost there

User Image ArgusDune1971 Posted - 4 days ago

$BCTX If ever a gif was destined to describe being a BriaCell investor, this is it 😂

User Image Lenny04 Posted - 4 days ago

$BCTX @Fvalstounge Dr. Williams said something along the lines of „stay tuned“ after you asked him why there weren’t any institutional buys in the recent past, right? Do you assume some announcement regarding in near future ?

User Image Blameyourselfirst Posted - 4 days ago

$BCTX Now buy the low of the day signal 2.14

User Image BabyAlien Posted - 4 days ago

$BCTX up

User Image rockitpicks Posted - 4 days ago

$BCTX I can only hazard a guess that the short knows the insiders well and has no fear of shorting until he becomes aware of a major positive event on the horizon. Until then he is making money to the downside and will make a lot more to the upside when it goes into play. Ask Nancy Pelosi how that works.

User Image SimplyFanStacheTic Posted - 4 days ago

$BCTX haven’t seen it trading this low since 2021. Worth the risk with a 1.91 SL for me.

User Image ArgusDune1971 Posted - 4 days ago

$BCTX Looks like we have bottomed out. At least until the next time the stock shows a pulse and Briacell releases news just to hammer it under 2.

User Image My_Lai_1968 Posted - 4 days ago

$BCTX Word on the Street is that BCTX falls to $1.20/share by May 2.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Bondarenko Jamieson Chairman Chairman Dec 28 Buy 4.58 28,000 128,240 169,856 12/28/22
Bondarenko Jamieson Director Director Dec 20 Buy 5.35 22,000 117,700 141,856 12/20/22